VHL Breakthrough: An Expert Discussion Published -- Download video MP4 360p Recommendations 1:02:31 Shared Decision Making: Understanding Your Immunotherapy Options When You Have Kidney Cancer 22:38 Von Hippel-Lindau Disease: Clinical Update and New Drug Therapy 1:29:41 KCRS24 Session Five: Clinical and Scientific Updates in Kidney Cancer | KidneyCAN 53:35 All You Need to Know to be a Competitive MD PhD Applicant 1:17:43 KCRS24 Session Six: Immunotherapy Advances in Kidney Cancer | KidneyCAN 1:27:19 Mast cell activation disorder with Dr. Anne Maitland 18:51 Dr. Paul Offit on where we are with the COVID-19 pandemic | Public Health Update for Jan. 24, 2022 1:05:16 Protecting the Legitimacy of Medical Expertise: Combating Misinformation in Medicine 38:28 The Role of the Oncology Pharmacist for Patients with Kidney Cancer 42:41 KCRS24 Session Four: Ongoing Clinical Trials in Kidney Cancer/ Trials in Progress | KidneyCAN 3:54:38 Optogenetics: Illuminating the Path toward Causal Neuroscience Similar videos 04:58 Current Concepts in the Management of VHL 30:25 Role Of Renal Ablative Therapy and Minimally Invasive Surgery in VHL Treatment | Benjamin Chung, MD 40:40 Belzutifan for VHL-Associated Tumors: A Molecules to Medicine Success Story—Elaine T. Lam, MD, FACP 05:20 Treatment strategies for Von Hippel-Lindau syndrome 00:34 MyVHL and Dr. Eric Jonasch - The VHL Alliance 01:46 VHL: NEW DRUG FOR GENETIC DISEASE SHRINKS TUMORS 02:22 Raising awareness about VHL 09:35 LITESPARK-004: 36 month follow-up of belzutifan in Von Hippel-Lindau syndrome 03:28 MK-6482 to Treat Renal Cell Carcinoma in Von Hippel-Lindau Disease Patients 13:07 Rare Central Nervous System Tumors: Progress in Clinical Care and Research 29:08 FDA Approval of Belzutifan | Eric Jonasch, MD 02:39 Dr Rashmi Jain | My story - Living with VHL | Ask4healthcare | VHL | Von Hippel–Lindau Syndrome 03:30 Living with VHL a warriors story part 1 06:09 Belzutifan for VHL Disease-Associated Renal Cell Carcinoma More results